Taro Corporate
Taro U.S.A
Taro Canada
Taro Israel
Sun Pharma
Chattem Chemicals Inc.
Taro RX product details
Product Information
-
DIN:02336480
-
Active Ingredients :ranitidine hydrochloride
-
Innovator Name:Zantac®
-
Category:Histamine H2-receptor antagonist
-
Dosage form:Tablet
-
Strength:150mg
- Package size:
100 Bottle 500 Bottle - UPC Code:
876515000176 876515003085 -
Non-medicinal ingredients :colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, and microcrystalline cellulose. The film-coating suspension contains the following excipients: hydroxypropyl cellulose, hypromellose, and titanium dioxide
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02336502
-
Active Ingredients :ranitidine hydrochloride
-
Innovator Name:Zantac®
-
Category:Histamine H2-receptor antagonist
-
Dosage form:Tablet
-
Strength:300mg
- Package size:
100 Bottle 500 Bottle - UPC Code:
876515000190 876515003092 -
Non-medicinal ingredients :colloidal silicon dioxide, croscarmellose sodium, magnesium stearate, and microcrystalline cellulose. The film-coating suspension contains the following excipients: hydroxypropyl cellulose, hypromellose, and titanium dioxide
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here